These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [The surgical treatment of cancer of the middle lobe of the lung].
    Author: Rukosuev AA, Kotliarov EV.
    Journal: Vopr Onkol; 1992; 38(11):1329-33. PubMed ID: 1343164.
    Abstract:
    The immediate and long-term results of surgical treatment for cancer of the middle lobe of the lung in 84 patients are discussed. Radical procedure was used in 65 (77.4%) patients. Postoperative lethality was 6.1% (4 cases out of 65). 30.2% survived over 5 years. Regional lymphatic node involvement was found to significantly affect the end results. At zero involvement, 5-years survival was 38.7% whereas at involvement 1-2, it dropped to 8.3%. With regional nodes intact, midlobectomy was survived for more than 5 years by 20.0%, bilobectomy--71.4%, and pneumonectomy--35.7%. Maximal advantage is assured by bilobectomy since it allows for adequate lymphadendissection, midlobectomy being not radical enough for surgical treatment of lung cancer.
    [Abstract] [Full Text] [Related] [New Search]